Skip to main content

Anti-Cancer Drug Design is now published as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Publisher: Cognizant Communication Corporation

Volume 12, Number 5, 1997

Preface
pp. 311-313(3)
Author: Crooke, ST

Favourites:
ADD

Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeutics
pp. 315-326(12)
Authors: McGraw, K; McKay, R; Miraglia, L; Boggs, RT; Pribble, JP; Muller, M; Geiger, T; Fabbro, D; Dean, NM

Favourites:
ADD
Favourites:
ADD

Targeting c-myc in leukemia
pp. 373-381(9)
Authors: Calabretta, B; Skorski, T

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Immune stimulation - a class effect of phosphorothioate oligodeoxynucleotides in rodents
pp. 421-432(12)
Authors: Henry, SP; Monteith, DK; Bennett, CF; Levin, AA; Howard, RB; Flournoy, S; Crooke, ST

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more